Hervé Rubie

3.5k total citations
47 papers, 2.0k citations indexed

About

Hervé Rubie is a scholar working on Neurology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hervé Rubie has authored 47 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Neurology, 15 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hervé Rubie's work include Neuroblastoma Research and Treatments (28 papers), Cancer therapeutics and mechanisms (13 papers) and Sarcoma Diagnosis and Treatment (9 papers). Hervé Rubie is often cited by papers focused on Neuroblastoma Research and Treatments (28 papers), Cancer therapeutics and mechanisms (13 papers) and Sarcoma Diagnosis and Treatment (9 papers). Hervé Rubie collaborates with scholars based in France, United Kingdom and Italy. Hervé Rubie's co-authors include Jean Michon, Dominique Plantaz, Olivier Delattre, Olivier Hartmann, Dominique Valteau‐Couanet, Odile Oberlin, Gudrun Schleiermacher, Jérôme Couturier, Alain Robert and Françoise Méchinaud and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Cancer.

In The Last Decade

Hervé Rubie

45 papers receiving 2.0k citations

Peers

Hervé Rubie
Max M. van Noesel Netherlands
Niels Carlsen Denmark
Harriet Druker Canada
M.C. Baranzelli France
J M Zucker France
Anne Sophie Defachelles France
Jean Claude Gentet France
Giovannella Palmieri Italy
Astrid Gnekow Germany
Maria Rita Castellani Italy
Max M. van Noesel Netherlands
Hervé Rubie
Citations per year, relative to Hervé Rubie Hervé Rubie (= 1×) peers Max M. van Noesel

Countries citing papers authored by Hervé Rubie

Since Specialization
Citations

This map shows the geographic impact of Hervé Rubie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Rubie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Rubie more than expected).

Fields of papers citing papers by Hervé Rubie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Rubie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Rubie. The network helps show where Hervé Rubie may publish in the future.

Co-authorship network of co-authors of Hervé Rubie

This figure shows the co-authorship network connecting the top 25 collaborators of Hervé Rubie. A scholar is included among the top collaborators of Hervé Rubie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hervé Rubie. Hervé Rubie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guellec, Sophie Le, Elizabeth Cohen‐Jonathan Moyal, Thomas Filleron, et al.. (2013). The β5/focal adhesion kinase/glycogen synthase kinase 3β integrin pathway in high-grade osteosarcoma: a protein expression profile predictive of response to neoadjuvant chemotherapy. Human Pathology. 44(10). 2149–2158. 10 indexed citations
2.
Giannatale, Angela Di, Annick S. Devos, Ariane Boubaker, et al.. (2013). Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma study. European Journal of Cancer. 50(1). 170–177. 40 indexed citations
3.
Owens, Cormac, Valérie Laurence, Lofti Benboubker, et al.. (2012). Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma. Cancer Chemotherapy and Pharmacology. 71(2). 399–404. 6 indexed citations
4.
Munzer, Caroline, Dominique Valteau‐Couanet, Carole Coze, et al.. (2011). A dose‐intensive approach (NB96) for induction therapy utilizing sequential high‐dose chemotherapy and stem cell rescue in high‐risk neuroblastoma in children over 1 year of age. Pediatric Blood & Cancer. 57(6). 965–971. 5 indexed citations
5.
Angelini, Paola, Dominique Plantaz, Bruno De Bernardi, et al.. (2011). Late sequelae of symptomatic epidural compression in children with localized neuroblastoma. Pediatric Blood & Cancer. 57(3). 473–480. 22 indexed citations
6.
Rubie, Hervé, Birgit Geoerger, Didier Frappaz, et al.. (2010). Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours. European Journal of Cancer. 46(15). 2763–2770. 15 indexed citations
7.
Machin, David, Andreas Faldum, Barbara Hero, et al.. (2010). Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project. European Journal of Cancer. 47(4). 561–571. 74 indexed citations
8.
9.
Castex, Marie‐Pierre, Hervé Rubie, Michaël C.G. Stevens, et al.. (2007). Extraosseous Localized Ewing Tumors: Improved Outcome With Anthracyclines—The French Society of Pediatric Oncology and International Society of Pediatric Oncology. Journal of Clinical Oncology. 25(10). 1176–1182. 52 indexed citations
10.
Munzer, Caroline, F. Ménégaux, Brigitte Lacour, et al.. (2007). Birth‐related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: The ESCALE study (SFCE). International Journal of Cancer. 122(10). 2315–2321. 25 indexed citations
11.
Gomez‐Brouchet, Anne, Franck Accadbled, Hervé Rubie, et al.. (2007). Rapid Development of an Osteosarcoma After Surgical Resection of an Osteochondroma. Journal of Pediatric Orthopaedics. 27(6). 640–642. 1 indexed citations
12.
13.
Sauvat, Frédérique, Sabine Sarnacki, Hervé J. Brisse, et al.. (2002). Outcome of suprarenal localized masses diagnosed during the perinatal period. Cancer. 94(9). 2474–2480. 77 indexed citations
14.
Duchayne, Éliane, Cécile Demur, Hervé Rubie, Alain Robert, & Nicole Dastugue. (1999). Diagnosis of Acute Basophilic Leukemia. Leukemia & lymphoma. 32(3-4). 269–278. 40 indexed citations
15.
Dastugue, Nicole, Éliane Duchayne, Emilienne Kühlein, et al.. (1997). Acute basophilic leukaemia and translocation t(X;6)(p11;q23). British Journal of Haematology. 98(1). 170–176. 30 indexed citations
16.
Chatelut, Étienne, Alan V. Boddy, Bin Peng, et al.. (1996). Population pharmacokinetics of carboplatin in children*. Clinical Pharmacology & Therapeutics. 59(4). 436–443. 42 indexed citations
17.
18.
Rubie, Hervé, Laurence Gladieff, Alain Robert, et al.. (1994). Childhood anaplastic large cell lymphoma Ki‐1/CD30: Clinicopathologic features of 19 cases. Medical and Pediatric Oncology. 22(3). 155–161. 26 indexed citations
19.
Dastugue, Nicole, Alain Robert, Catherine Payen, et al.. (1992). Prognostic significance of karyotype in a twelve-year follow-up in childhood acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 64(1). 49–55. 11 indexed citations
20.
Rubie, Hervé, Olivier Hartmann, Laurence Brugières, et al.. (1991). Nonmetastatic thoracic neuroblastomas: A review of 40 cases. Medical and Pediatric Oncology. 19(4). 253–257. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Max M. van Noesel Breakdown of academic impact, for papers by Niels Carlsen Breakdown of academic impact, for papers by Harriet Druker Breakdown of academic impact, for papers by M.C. Baranzelli Breakdown of academic impact, for papers by J M Zucker Breakdown of academic impact, for papers by Anne Sophie Defachelles Breakdown of academic impact, for papers by Jean Claude Gentet Breakdown of academic impact, for papers by Giovannella Palmieri Breakdown of academic impact, for papers by Astrid Gnekow Breakdown of academic impact, for papers by Maria Rita Castellani
Rankless by CCL
2026